ANPI Angiotech Pharmaceuticals - Common Shares (MM)

Angiotech Pharmaceuticals to participate in Morgan Stanley Conference VANCOUVER, June 7 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), is scheduled to participate in the Morgan Stanley Small Cap Executive Conference. Dr. Rui Avelar, Senior Vice President, Medical Affairs and Communications of Angiotech, will be making a 15-minute presentation at the conference on Tuesday, June 14th, 2005 at 8:00 AM EST (5:00 AM PST). A live audio only webcast of Dr. Avelar's remarks will be available to all interested parties at Angiotech's website at http://www.angiotech.com/ in the Investor Relations section. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins. Vancouver-based Angiotech Pharmaceuticals, Inc. is a specialty pharmaceutical company pioneering the combination of pharmaceutical compounds with medical devices and biomaterials to both create novel solutions for poorly addressed disease states and dramatically improve surgical outcomes. To find out more about Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at http://www.angiotech.com/. CONTACTS: Todd Young, VP, Investor Relations and Communications, Angiotech Pharmaceuticals, Inc. (604) 221-7676 ext 6933 Rui Avelar, SVP, Medical Affairs and Communications, Angiotech Pharmaceuticals, Inc. (604) 221-7676 ext 6996 DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Todd Young, VP, Investor Relations and Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7676 ext 6933; Rui Avelar, SVP, Medical Affairs and Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7676 ext 6996

Copyright